WO1993006208A1 - Fatty acid microencapsulated enterococcus for use with poultry - Google Patents
Fatty acid microencapsulated enterococcus for use with poultry Download PDFInfo
- Publication number
- WO1993006208A1 WO1993006208A1 PCT/US1992/007589 US9207589W WO9306208A1 WO 1993006208 A1 WO1993006208 A1 WO 1993006208A1 US 9207589 W US9207589 W US 9207589W WO 9306208 A1 WO9306208 A1 WO 9306208A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- probiotic
- fatty acid
- feed
- poultry
- bacteria
- Prior art date
Links
- 235000014113 dietary fatty acids Nutrition 0.000 title claims abstract description 32
- 229930195729 fatty acid Natural products 0.000 title claims abstract description 32
- 239000000194 fatty acid Substances 0.000 title claims abstract description 32
- 150000004665 fatty acids Chemical class 0.000 title claims abstract description 32
- 244000144977 poultry Species 0.000 title claims abstract description 22
- 241000194033 Enterococcus Species 0.000 title description 2
- 239000004005 microsphere Substances 0.000 claims abstract description 28
- 241000194031 Enterococcus faecium Species 0.000 claims abstract description 16
- 239000006041 probiotic Substances 0.000 claims description 67
- 235000018291 probiotics Nutrition 0.000 claims description 67
- 230000000529 probiotic effect Effects 0.000 claims description 62
- 238000000034 method Methods 0.000 claims description 31
- 239000000203 mixture Substances 0.000 claims description 13
- 235000021588 free fatty acids Nutrition 0.000 claims description 12
- 235000021355 Stearic acid Nutrition 0.000 claims description 10
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 10
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 10
- 239000008117 stearic acid Substances 0.000 claims description 10
- 230000006872 improvement Effects 0.000 abstract description 8
- 239000003674 animal food additive Substances 0.000 abstract description 4
- 241000894006 Bacteria Species 0.000 description 29
- 235000013594 poultry meat Nutrition 0.000 description 17
- 210000000481 breast Anatomy 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 13
- 230000008569 process Effects 0.000 description 13
- 239000003242 anti bacterial agent Substances 0.000 description 12
- 229940088710 antibiotic agent Drugs 0.000 description 12
- 241000271566 Aves Species 0.000 description 10
- 239000011159 matrix material Substances 0.000 description 10
- 238000011282 treatment Methods 0.000 description 10
- MVTQIFVKRXBCHS-SMMNFGSLSA-N N-[(3S,6S,12R,15S,16R,19S,22S)-3-benzyl-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide (10R,11R,12E,17E,19E,21S)-21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),6,12,17,19,25(28)-hexaene-2,8,14,23-tetrone Chemical compound CC(C)[C@H]1OC(=O)C2=CCCN2C(=O)c2coc(CC(=O)C[C@H](O)\C=C(/C)\C=C\CNC(=O)\C=C\[C@H]1C)n2.CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@@H]2CC(=O)CCN2C(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCN2C1=O)c1ccccc1 MVTQIFVKRXBCHS-SMMNFGSLSA-N 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 7
- 230000003115 biocidal effect Effects 0.000 description 6
- 244000144992 flock Species 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 230000004584 weight gain Effects 0.000 description 6
- 235000019786 weight gain Nutrition 0.000 description 6
- 241000287828 Gallus gallus Species 0.000 description 5
- 238000005453 pelletization Methods 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- 230000037396 body weight Effects 0.000 description 4
- 235000013330 chicken meat Nutrition 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000005538 encapsulation Methods 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 230000003442 weekly effect Effects 0.000 description 4
- 235000019738 Limestone Nutrition 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000001332 colony forming effect Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 239000006028 limestone Substances 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- POMORUSPLDFVEK-PHXAWWDYSA-N (4r)-5-[[(2s,3s)-1-[[(2s)-6-amino-1-[[(2r)-5-amino-1-[[(2s,3s)-1-[[(2r)-1-[[(2s)-1-[[(2r)-1-[[(1s)-3-amino-1-carboxy-3-oxopropyl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-3-(1h-imidazol-5-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-methy Chemical compound OC1=CC=CC=C1C(=O)OCOC(=O)C1=CC=CC=C1O.C1SC(C(N)C(C)CC)=NC1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)CC1=CC=CC=C1 POMORUSPLDFVEK-PHXAWWDYSA-N 0.000 description 2
- 235000019783 Bacitracin Methylene Disalicylate Nutrition 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 235000019764 Soybean Meal Nutrition 0.000 description 2
- 239000004188 Virginiamycin Substances 0.000 description 2
- 108010080702 Virginiamycin Proteins 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 229940032022 bacitracin methylene disalicylate Drugs 0.000 description 2
- 108010054309 bacitracin methylenedisalicylic acid Proteins 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 2
- 229940038472 dicalcium phosphate Drugs 0.000 description 2
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000007952 growth promoter Substances 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000004455 soybean meal Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 235000019373 virginiamycin Nutrition 0.000 description 2
- 229960003842 virginiamycin Drugs 0.000 description 2
- ZNAIHAPCDVUWRX-DUCUPYJCSA-N (4s,4as,5as,6s,12ar)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;4-amino-n-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-t Chemical compound CC1=CC(C)=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1.C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O ZNAIHAPCDVUWRX-DUCUPYJCSA-N 0.000 description 1
- 239000004099 Chlortetracycline Substances 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 229930182504 Lasalocid Natural products 0.000 description 1
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 description 1
- GAOZTHIDHYLHMS-UHFFFAOYSA-N Monensin A Natural products O1C(CC)(C2C(CC(O2)C2C(CC(C)C(O)(CO)O2)C)C)CCC1C(O1)(C)CCC21CC(O)C(C)C(C(C)C(OC)C(C)C(O)=O)O2 GAOZTHIDHYLHMS-UHFFFAOYSA-N 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 239000004189 Salinomycin Substances 0.000 description 1
- KQXDHUJYNAXLNZ-XQSDOZFQSA-N Salinomycin Chemical compound O1[C@@H]([C@@H](CC)C(O)=O)CC[C@H](C)[C@@H]1[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@@H]1[C@@H](C)C[C@@H](C)[C@@]2(C=C[C@@H](O)[C@@]3(O[C@@](C)(CC3)[C@@H]3O[C@@H](C)[C@@](O)(CC)CC3)O2)O1 KQXDHUJYNAXLNZ-XQSDOZFQSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 239000004182 Tylosin Substances 0.000 description 1
- 229930194936 Tylosin Natural products 0.000 description 1
- 235000019742 Vitamins premix Nutrition 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960000427 carbadox Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 1
- 229960004475 chlortetracycline Drugs 0.000 description 1
- 235000019365 chlortetracycline Nutrition 0.000 description 1
- CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000008393 encapsulating agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- BBMULGJBVDDDNI-OWKLGTHSSA-N lasalocid Chemical compound C([C@@H]1[C@@]2(CC)O[C@@H]([C@H](C2)C)[C@@H](CC)C(=O)[C@@H](C)[C@@H](O)[C@H](C)CCC=2C(=C(O)C(C)=CC=2)C(O)=O)C[C@](O)(CC)[C@H](C)O1 BBMULGJBVDDDNI-OWKLGTHSSA-N 0.000 description 1
- 229960000320 lasalocid Drugs 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 description 1
- 229960005287 lincomycin Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- BPMVRAQIQQEBLN-OBPBNMOMSA-N methyl n-[(e)-(1-hydroxy-4-oxidoquinoxalin-4-ium-2-ylidene)methyl]iminocarbamate Chemical compound C1=CC=C2N(O)C(=C/N=NC(=O)OC)/C=[N+]([O-])C2=C1 BPMVRAQIQQEBLN-OBPBNMOMSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229960000625 oxytetracycline Drugs 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000000275 quality assurance Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960001548 salinomycin Drugs 0.000 description 1
- 235000019378 salinomycin Nutrition 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- XOIQMTLWECTKJL-FBZUZRIGSA-M sodium;(2s,3r,4s)-4-[(2s,5r,7s,8r,9s)-2-[(2r,5s)-5-ethyl-5-[(2r,3s,5r)-5-[(2s,3s,5r,6r)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-3-methyloxolan-2-yl]oxolan-2-yl]-7-hydroxy-2,8-dimethyl-1,10-dioxaspiro[4.5]decan-9-yl]-3-methoxy-2-methylpentanoate Chemical compound [Na+].C([C@@](O1)(C)[C@H]2CC[C@@](O2)(CC)[C@H]2[C@H](C[C@@H](O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C[C@@]21C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C([O-])=O)O2 XOIQMTLWECTKJL-FBZUZRIGSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960002135 sulfadimidine Drugs 0.000 description 1
- ASWVTGNCAZCNNR-UHFFFAOYSA-N sulfamethazine Chemical compound CC1=CC(C)=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 ASWVTGNCAZCNNR-UHFFFAOYSA-N 0.000 description 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229960004059 tylosin Drugs 0.000 description 1
- 235000019375 tylosin Nutrition 0.000 description 1
- WBPYTXDJUQJLPQ-VMXQISHHSA-N tylosin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 WBPYTXDJUQJLPQ-VMXQISHHSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
Definitions
- Growth enhancers in the form of antibiotics have been used extensively for poultry, namely chickens and turkey.
- Growth enhancers such as Stafac® and BMD ® (bacitracin methylene disalicylate) are known antibiotics and have been used at sub-therapeutic levels of for example, 10 grams per ton and 25 grams per ton as feed additives in order to promote
- probiotics do have some difficulty in maintaining a stable product. Typically, the probiotic is used at a fairly low level, added to feed at perhaps a 0.1% level. However, unused probiotic containing feed or feed additive product is often stored by the farmers for long periods of time. This storage many times is under conditions where there is some moisture and high temperature. In many instances there is just enough moisture that the bacteria are activated or start to grow, but yet there is an insufficient amount of moisture to sustain them. As a result they die. Thus, the activity of the probiotic is stopped. In other instances, the addition of antibiotics to the probiotic containing feed or feed additive adversely interacts with the bacteria, particularly if there are small amounts of moisture present and thus again bacteria are killed. Thus, there is a significant problem of long term storage stability for
- Certain features of poultry are especially desirable to achieve if possible. Those include an increased rate of weight gain, better feed
- uniformity of flock weight is important because the most desirable area for tissue deposit is the breast in order to yield a high amount of choice meat. Thus, weight gain is not only important, but where the weight is gained on the carcass is also important. Uniformity of flock weight is important because if more birds are normal in size, less hand labor is required and processors can more extensively rely on machine processing. On the other hand, if the birds vary considerably from very small birds to very large birds, even though the overall flock weight may be the same, the smaller birds and the larger birds require a great deal more hand labor and because of their lack of uniformity in size, cannot be processed easily by machine. Thus, uniformity of flock weight with a high percentage distribution within the normal size range so that chickens can process by standardized machinery is a desirable feature.
- inventions to provide a poultry probiotic which contains no antibiotics and contains only fatty acid microencapsulated naturally occurring organisms.
- DSM is a Bacterial Culture collection in Germany. DMS stands for Deutsche Sammlung von Mikroorganismen located in Braunschweig, West
- invention to provide a probiotic which, for poultry, provides increased rate of weight gain, which
- An even further primary objective of the present invention is to provide probiotics suitable for poultry feed ration addition which contains bacteria that are in microsphere form using a special rotary technique using free fatty acid matrix.
- Another objective of the present invention is to provide a probiotic which has stability at levels within the range of from 3 months to 6 months without any significant organism count reduction.
- Another objective of the present invention is to provide a process of rotary formation of spheres of the dried bacteria which provides having uniform size.
- Another objective of the present invention is to provide rotary disc spheres of dried bacteria which are free flowing, and easily processable with poultry feed rations.
- Figure 4 is a graph showing breast yield
- Figure 5 is a graph showing body weight
- Figures 4 and 5 show a control, use of an
- the invention is a method and composition of growth promotion for poultry which comprises adding to the normal poultry feed ration a small but growth promoting effective amount of a probiotic which contains dried, fatty acid microspheres of
- Enterococcus faecium 301 DSM No. DSM-Nr. 4789, and dried fatty acid microepheres of Enterococcus faecium 202, DSM No. DSM-Nr. 4788, where preferably the fatty microspheres are formed by rotary disc drying.
- a fatty acid employed may be any one of the C 12 to C 24 free fatty acids, but is preferably stearic acid.
- the organisms are preferably present in about equal amounts but may vary within the range from about 30% to about 70% of one of the organisms with the balance being the other.
- organisms provide the desirable features of the present invention, namely increased rate of weight gain, better feed conversion, increased yield of breast meat, and increased uniformity of flock weight.
- the fact is that they do, provided that both are used in combination so that they can somehow interact with each other, and providing that they are used within the range herein expressed. It is these combinations of features which some how interact and co-act to provide the desirable features of the present invention which allow significantly improved poultry carcass, meat quality and processing.
- the amount of probiotic added to the feed ration can vary considerably but generally will be within the range of from about 0.5 pounds to about 2.0 pounds per ton of feed, generally from about 0.8 pounds to about 1.2 pounds per ton of feed, and typically at about 1 pound per ton of feed.
- the organism count, that is the number of colony forming units per gram present in the probiotic can also vary within the range of from about 1 x 10 6 CFU/gm to about 2 x 10 9 CFU/gm, but is preferably at about 2 x
- Growth promoters now used include antibotics such as
- the method of processing of the organisms is not critical as long as the organisms can be kept alive to delivery to the animal, and placed in a form so that it will combine with animal feed well and is of a generally uniform size so that dosage may be controlled.
- microspheres are formed wherein each sphere constitutes a plurality of bacteria in a free fatty acid matrix rather than an individual microencapsulator of each bacteria in a coating or film like layer of fatty acid.
- the preferred encapsulating agent is a C 12 to C 24 free fatty acid. While mixtures of fatty acids may be employed, it is preferred that a single pure free fatty acid be employed. It is also preferred that the free fatty acid be an unsaturated fatty acid, with the most preferred being stearic acid.
- the fatty acid have a melting point less than 75°C, preferably within the range of 40°C to 75°C. It must, of course, be solid at room temperature in order to be an effective matrix. All free fatty acids falling within the range of chemical
- the bacteria are typically freeze-dried bacteria as placed in the product. Thus, they can be revived by moisture addition.
- the microspheres generally comprise from about 50% to over 90% by weight of the fatty acid component with the balance being bacterial culture.
- the preferred range is from about 60% to about 75% fatty acid. If too little fatty acid is used, the matrix will be inadequate for protection. On the other hand, if too much is used, the matrix will be too thick and results in inadequate release in the gut.
- the process as used in this invention is a rotary disc microsphere formation process.
- a slurry of the bacteria and fatty acid components are thoroughly mixed with the mixture being added at a uniform rate onto the center of a rotating stainless steel disc. It is there flung outwardly as a result of
- centrifugal force and forms a microsphere. It is then collected in a cooling chamber maintained at ambient conditions or slightly lower, sized and readied for packaging.
- Microencapsulation provides a shell coating around an object, and bacteria have proven to be too small, too hard to keep alive or provide in a uniform size to be of practical usefulness. With microsphere formation, particularly with agents used in this invention is used, the stability of the resulting bacteria, even when subjected to some moisture and antibiotics, will be for from three to six months with the
- the rotary disk typically employing a 4"-6" rotary disc
- the rotary disk can be run at the rate of from 2000 rpm to 4000 rpm, preferably about 2500 rpm to 3200 rpm with a feed rate of from 50 grams to 200 grams per minute.
- the preferred conditions presently known are use of stearic acid, use of two hereinbefore described organisms, a four inch rotary disc, 3000 rpm and a feed rate of 100 grams per minute with a bacteria/stearic acid slurry of 35% bacteria, 65% stearic acid.
- a product having a particle size of from 75 microns to 300 microns will be achieved, with a preferred level of less than 250 microns.
- Example 1 through 4 and Figures 1, 2, and 3 relate to the invention of my prior case.
- Example 5, and tables 2-10 relate to the process of this present invention for a poultry probiotic.
- Example 1 correlates with Figure 1. It shows the product stability of two different strains of
- CFU colony forming unit
- Example 2 is to be interpreted in connection with Figure 2.
- the figure shows the stability of individual microsphered strains when mixed in a typical feed ration in the presence of three poultry antibiotics.
- the ration consisted of the following:
- Example 3 is to be interpreted in conjunction with Figure 3. It shows the stability of the
- Enterococcus faecium microspheres in feed in the presence of different antibiotics The ration consisted of 60% fine cracked corn, 38% soybean meal and 2% limestone with a moisture content of about 14%. Culture was added to a level of approximately 10 CFU/gm feed and mixed. Ten pound aliquots were stored in sealed bags at 20 C and sampled weekly for 16 weeks. The antibiotics were included in the ration at the following levels:
- Table 1 is a list of the minimum times for a 1og loss in colony forming units (CFU). Table 1
- Example 4 the stability of product after pelletizing for use of a chicken feed product was determined.
- the microsphere formation conditions were as earlier described.
- the conditions used in this study were the following:
- Pellets were stored in unsealed bags and sampled weekly for CFU determination.
- the pelletized product was not adversely affected in stability by the conditions of pelletizing.
- the pelletized product showed stability equal to the unpelletized product.
- Control, M a selected, encapsulated probiotic cultures containing Enterococcus faecium 301, DSM No.
- DSM-Nr. 4788 each rotary disc fatty acid encapsulated as described in Example 1 and each present as 50% of the probiotic applied at 1 x 10 5 CFU/g of feed, mash
- a mixer test was conducted for each production phase. The test was designed to ensure that the probiotic was uniformly distributed at appropriate levels in the feed and that it survived pelleting. Each batch was sampled at the time of bagging with 4 equally spaced samples for the mash treatments and 10 equally spaced samples for the pelleted treatments (i.e. bags 1, 3, 5,..., 35, 37, and 39).
- Alternate floor pens within a treatment had non- contaminated feed sampled during weeks 1 and 4; with the remaining pens sampled on weeks 2 and 6 during the feeding study.
- Probiotic regardless of processing, improved (P ⁇ .05) feed conversion over the respective Control while increasing (P ⁇ .05) weight gain over the Control only in the mash feed (Table 4).
- the product was at its desired level and strain composition (Table 5).
- Probiotic was uniformly distributed within the feed. Probiotic, M was at its desired level while probiotic, P was 1 to 1-1/2 log higher than desired for the starter and grower rations ( Table 6). The high counts for probiotic, P were a result of
- Pelleting increased the average breast weight by 15 g over mash.
- Probiotic increased the average breast weight and uniformity (Figure 4) over the Control with the greatest improvement found in mash.
- Stafac® 10 showed the greatest improvement in uniformity for the pelleted feeds.
- probiotic treatments produced a shorter (P>.05) small intestinal length than either of the Controls and Stafac® when expressed as actual length, a ratio of either body weight, or breast weight (Table 9).
- Probiotic, M had a lighter (P>.05) small intestinal weight than Control, M when
- probiotic, P treated birds produced no off- flavor when compared to Stafac® 10 (Table 10).
- probiotic, P was perceived to have enhanced the flavor of the thigh/leg when compared to Control, P.
- this enhancement of flavor was not observed in the first trial.
- Pen size 4.2' x 15.5' one tube feeder, one hanging waterer, pine shavings on dirt, power and evaporative cooling system and well insulated, forced hot-air heat, curtain sidewall building.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Birds (AREA)
- Animal Husbandry (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Fodder In General (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Feed For Specific Animals (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19920920241 EP0604543A4 (en) | 1991-09-20 | 1992-09-09 | Fatty acid microencapsulated enterococcus for use with poultry. |
JP5506091A JPH06511148A (ja) | 1991-09-20 | 1992-09-09 | 家禽用脂肪酸マイクロカプセル化腸球菌 |
BR9206505A BR9206505A (pt) | 1991-09-20 | 1992-09-09 | Enterococcus microencapsulado em ácido graxo para uso com aves. |
RO94-00449A RO113477B1 (ro) | 1991-09-20 | 1992-09-09 | Metodă pentru stimularea creşterii păsărilor de curte |
CS94595A CZ280601B6 (cs) | 1991-09-20 | 1992-09-09 | Způsob podpory růstu drůbeže a enterokoky mikrozapouzdřené mastnými kyselinami pro použití u drůbeže |
RU9294019485A RU2093571C1 (ru) | 1991-09-20 | 1992-09-09 | Способ стимулирования роста домашней птицы и препарат на основе пробиотика |
SK324-94A SK278992B6 (sk) | 1991-09-20 | 1992-09-09 | Probiotická zmes na podporu rastu hydiny |
BG98665A BG62175B1 (bg) | 1991-09-20 | 1994-03-17 | Метод и пробиотик за стимулиране растежа на птици |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76317591A | 1991-09-20 | 1991-09-20 | |
US07/763,175 | 1991-09-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1993006208A1 true WO1993006208A1 (en) | 1993-04-01 |
Family
ID=25067078
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1992/007589 WO1993006208A1 (en) | 1991-09-20 | 1992-09-09 | Fatty acid microencapsulated enterococcus for use with poultry |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0604543A4 (cs) |
JP (1) | JPH06511148A (cs) |
BG (1) | BG62175B1 (cs) |
BR (1) | BR9206505A (cs) |
CA (1) | CA2116525A1 (cs) |
CZ (1) | CZ280601B6 (cs) |
HU (1) | HUT67466A (cs) |
MX (1) | MX9205329A (cs) |
RO (1) | RO113477B1 (cs) |
RU (1) | RU2093571C1 (cs) |
SK (1) | SK278992B6 (cs) |
WO (1) | WO1993006208A1 (cs) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0631616A4 (en) * | 1992-03-17 | 1995-04-19 | Pioneer Hi Bred Int | ENTEROCOCCUS CONTAINED FATTY ACID MICROSPHERES TO INCREASE AND IMPROVE THE QUALITY OF THE BODY. |
EP0628072A4 (en) * | 1992-02-26 | 1995-12-20 | Pioneer Hi Bred Int | DRIED, MICROSPHERICAL TURNTABLE OF MICROORGANISMS. |
WO1997045530A1 (fr) * | 1996-05-27 | 1997-12-04 | UZILOVA, Irina Semenovna, Heiress of UZILOV | Utilisation de souches de streptococcus faecium et composition a base de ces souches |
WO2003071883A1 (en) | 2002-02-28 | 2003-09-04 | Centro Sperimentale Del Latte S.P.A. | Dietetic and/or pharmaceutical compositions for human and/or animal use based on probiotic microbial preparations |
WO2005009139A1 (en) * | 2003-07-30 | 2005-02-03 | Chr. Hansen A/S | A farm animal product with probiotic enterococcus bacteria |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10105306A1 (de) * | 2001-02-02 | 2002-08-22 | Nutrinova Gmbh | Futtermittel für die Nutztieraufzucht enthaltend Sorbinsäure und Enzyme |
RU2217493C2 (ru) * | 2001-02-22 | 2003-11-27 | Чекасина Елизавета Васильевна | Биопрепарат-пробиотик, способ его получения и штамм streptococcus faecium те-17 для получения биопрепарата-пробиотика для животных и птицы |
RU2283587C1 (ru) * | 2005-02-28 | 2006-09-20 | Федеральное Государственное Учреждение Государственный Природный Заповедник "Болоньский" | Способ карантинного содержания птенцов дальневосточного аиста |
RU2292156C1 (ru) * | 2005-07-07 | 2007-01-27 | Уральская Государственная сельскохозяйственная академия (УрГСХА) | Способ выращивания бройлеров |
RU2359465C1 (ru) * | 2008-03-11 | 2009-06-27 | Государственное образовательное учреждение высшего профессионального образования "Орловский государственный технический университет" (ОрелГТУ) | Кормовая добавка для молодняка свиней |
RU2393715C2 (ru) * | 2008-06-09 | 2010-07-10 | Федеральное государственное образовательное учреждение высшего профессионального образования Новосибирский государственный аграрный университет | Способ повышения продуктивности сельскохозяйственной птицы |
RU2541389C1 (ru) * | 2013-07-16 | 2015-02-10 | Государственное научное учреждение Северо-Кавказский зональный научно-исследовательский ветеринарный институт (ГНУ СКЗНИВИ) Российской академии сельскохозяйственных наук | Способ стимуляции роста птицы |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3959493A (en) * | 1971-03-17 | 1976-05-25 | Rumen Chemie, Ag | Rumen bypass products comprising biologically active substances protected with aliphatic fatty acids |
GB2016043A (en) * | 1978-03-08 | 1979-09-19 | Danochemo As | Bacteria-containing product for use in animal feeds, and its production |
US4675140A (en) * | 1984-05-18 | 1987-06-23 | Washington University Technology Associates | Method for coating particles or liquid droplets |
US4710379A (en) * | 1984-06-19 | 1987-12-01 | Kabushiki Kaisya Advance Kaihatsu Kenkyujo | Intestinal microflora-improving agent |
US4713245A (en) * | 1984-06-04 | 1987-12-15 | Mitsui Toatsu Chemicals, Incorporated | Granule containing physiologically-active substance, method for preparing same and use thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU9301855D0 (en) * | 1990-12-31 | 1993-12-28 | Pioneer Hi Bred Int | Dried, rotary disc fatty acid microencapsulated bacteria |
-
1992
- 1992-09-09 JP JP5506091A patent/JPH06511148A/ja active Pending
- 1992-09-09 SK SK324-94A patent/SK278992B6/sk unknown
- 1992-09-09 HU HU9400794A patent/HUT67466A/hu unknown
- 1992-09-09 EP EP19920920241 patent/EP0604543A4/en not_active Withdrawn
- 1992-09-09 RU RU9294019485A patent/RU2093571C1/ru active
- 1992-09-09 CA CA002116525A patent/CA2116525A1/en not_active Abandoned
- 1992-09-09 BR BR9206505A patent/BR9206505A/pt not_active Application Discontinuation
- 1992-09-09 CZ CS94595A patent/CZ280601B6/cs unknown
- 1992-09-09 WO PCT/US1992/007589 patent/WO1993006208A1/en not_active Application Discontinuation
- 1992-09-09 RO RO94-00449A patent/RO113477B1/ro unknown
- 1992-09-18 MX MX9205329A patent/MX9205329A/es unknown
-
1994
- 1994-03-17 BG BG98665A patent/BG62175B1/bg unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3959493A (en) * | 1971-03-17 | 1976-05-25 | Rumen Chemie, Ag | Rumen bypass products comprising biologically active substances protected with aliphatic fatty acids |
GB2016043A (en) * | 1978-03-08 | 1979-09-19 | Danochemo As | Bacteria-containing product for use in animal feeds, and its production |
US4675140A (en) * | 1984-05-18 | 1987-06-23 | Washington University Technology Associates | Method for coating particles or liquid droplets |
US4713245A (en) * | 1984-06-04 | 1987-12-15 | Mitsui Toatsu Chemicals, Incorporated | Granule containing physiologically-active substance, method for preparing same and use thereof |
US4710379A (en) * | 1984-06-19 | 1987-12-01 | Kabushiki Kaisya Advance Kaihatsu Kenkyujo | Intestinal microflora-improving agent |
Non-Patent Citations (2)
Title |
---|
ATCC Catalogue of Bacteria & Bacteriophagese, 17th edition, issued 1989, page 79, see entire document. * |
See also references of EP0604543A4 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0628072A4 (en) * | 1992-02-26 | 1995-12-20 | Pioneer Hi Bred Int | DRIED, MICROSPHERICAL TURNTABLE OF MICROORGANISMS. |
EP0631616A4 (en) * | 1992-03-17 | 1995-04-19 | Pioneer Hi Bred Int | ENTEROCOCCUS CONTAINED FATTY ACID MICROSPHERES TO INCREASE AND IMPROVE THE QUALITY OF THE BODY. |
WO1997045530A1 (fr) * | 1996-05-27 | 1997-12-04 | UZILOVA, Irina Semenovna, Heiress of UZILOV | Utilisation de souches de streptococcus faecium et composition a base de ces souches |
WO2003071883A1 (en) | 2002-02-28 | 2003-09-04 | Centro Sperimentale Del Latte S.P.A. | Dietetic and/or pharmaceutical compositions for human and/or animal use based on probiotic microbial preparations |
WO2005009139A1 (en) * | 2003-07-30 | 2005-02-03 | Chr. Hansen A/S | A farm animal product with probiotic enterococcus bacteria |
Also Published As
Publication number | Publication date |
---|---|
CZ280601B6 (cs) | 1996-03-13 |
BG62175B1 (bg) | 1999-04-30 |
HU9400794D0 (en) | 1994-06-28 |
EP0604543A1 (en) | 1994-07-06 |
HUT67466A (en) | 1995-04-28 |
BG98665A (bg) | 1995-03-31 |
CZ59594A3 (en) | 1994-07-13 |
EP0604543A4 (en) | 1994-07-27 |
MX9205329A (es) | 1993-07-01 |
RO113477B1 (ro) | 1998-07-30 |
SK278992B6 (sk) | 1998-05-06 |
JPH06511148A (ja) | 1994-12-15 |
CA2116525A1 (en) | 1993-04-01 |
BR9206505A (pt) | 1995-04-25 |
RU2093571C1 (ru) | 1997-10-20 |
SK32494A3 (en) | 1994-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10398156B2 (en) | Animal feed compositions and feed additives | |
US5292657A (en) | Process for preparing rotary disc fatty acid microspheres of microorganisms | |
PL193320B1 (pl) | Zastosowanie mieszaniny zawierającej gwajakol, tymol, engenol, kapsaicynę, taninę i krezol | |
WO1993006208A1 (en) | Fatty acid microencapsulated enterococcus for use with poultry | |
WO2003043441A1 (en) | Antimicrobial composition for animals | |
EP0565522B1 (en) | Dried, rotary disc fatty acid microencapsulated bacteria | |
WO1993019162A1 (en) | Fatty acid microspheres containing enterococcus for use to enhance growth and improve carcass quality | |
Ivannikova et al. | Effect of the feed additive ProVetin on the development of foals |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): BG BR CA CS HU JP PL RO RU |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL SE |
|
LE32 | Later election for international application filed prior to expiration of 19th month from priority date or according to rule 32.2 (b) | ||
LE32 | Later election for international application filed prior to expiration of 19th month from priority date or according to rule 32.2 (b) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2116525 Country of ref document: CA |
|
EX32 | Extension under rule 32 effected after completion of technical preparation for international publication | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1992920241 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV1994-595 Country of ref document: CZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 32494 Country of ref document: SK Ref document number: 94-00449 Country of ref document: RO |
|
WWP | Wipo information: published in national office |
Ref document number: 1992920241 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: PV1994-595 Country of ref document: CZ |
|
WWG | Wipo information: grant in national office |
Ref document number: PV1994-595 Country of ref document: CZ |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1992920241 Country of ref document: EP |